Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aradigm
Biotech
Grifols buys antibiotic assets from bankrupt partner Aradigm
The agreement sees Grifols waive a $32 million debt and pay $3 million in cash to take full ownership of three assets.
Nick Paul Taylor
Feb 24, 2020 8:57am
End of the line looms for Aradigm as it files for bankruptcy
Feb 19, 2019 10:46am
Aradigm executives jump ship after FDA snub
Feb 14, 2018 11:15am
FDA demands 2-year phase 3 from Aradigm
Jan 29, 2018 10:47am
Aradigm crashes after FDA panel votes down antibiotic
Jan 12, 2018 6:29am
